Wisse et al. argue how the pandemic amplifying vulnerabilities in countries' health-care systems is encouraging discourses for improvement that otherwise would have been disregarded.

Correlation European Harm Reduction Network reports on the impact covid-19 has had on front-line workers in harm reduction services.

Rigoni et al. analyse how CSOs contribute to developing effective measures aimed at reducing the harms of drug use.

Hiller-Sturmhoefel's study discovers people with drug dependencies are more likely to contract covid-19.

HRW's flagship publication includes multiple accounts on how countries around the world weaponise drug control to supress dissent and undermine human rights.

The Support. Don’t Punish campaign documents global efforts to progress harm reduction and drug policy reform as part of the 2020 Global Day of Action.

EHRA highlights ten case studies of harm reduction delivery during the pandemic situation.

HRI and IDPC discuss some of the current and emerging challenges specifically faced by people detained for drug offences and people in detention who use drugs.

Baltazar et al. shed light on the positive impact of access to drop-in centres and related services on the health of people who use drugs.

Plotko et al. found that, by and large, drug education for young people in the region remains anchored in the 'just say no' paradigm.

The EMCDDA provides an overview of the pandemic's impact in drug markets, service provision and people who use drugs.

The Council of the European Union approves the regional bloc's new Strategy, based on supply reduction, demand reduction and addressing drug-related harm.

The American Medical Association calls for an expansion of harm reduction efforts to tackle the overdose crisis.

The John Hopkins Bloomberg School of Public Health calls for increased attention and resources to curb the impact of the COVID-19 pandemic on the overdose crisis.

The Penington Institute explores the impact and success of the 2020 International Overdose Awareness Day.

The EMCDDA discusses the debates around the distribution and sale of low-THC cannabis products in Europe.

Conectas, IDPC, and INNPD provide input to the Committee on Economic, Social and Cultural Rights focusing on the serious violation of the rights to health of people who use drugs in Brazil.

IDPC and a coalition of NGOs provide recommendations to ensure that Nepalese national drug policies respect human rights and fundamental freedoms.

Miovský et al. suggest that the sustainability of harm reduction services in the region has been negatively affected by an under-investment in their institutionalisation.

Thomas D. Brothers et al. examine the encouraging metrics hospitals show in treating those with opioid dependencies and their positive impact after treatment has ended.